Infanrix-IPV+Hib

Infanrix-IPV+Hib Indications/Uses

haemophilus influenzae type b conjugate vaccine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
Full Prescribing Info
Indications/Uses
Infanrix-IPV+Hib is indicated for active immunisation in infants from the age of 2 months against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b.
Infanrix-IPV+Hib is also indicated as a booster dose for children who have previously been immunised with diphtheria, tetanus, pertussis (DTP), polio and Hib antigens.
The Hib component of the vaccine does not protect against diseases due to other serotypes of Haemophilus influenzae nor against meningitis caused by other organisms.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in